Unlocking and delivering the promise of therapeutic Nitric Oxide
Convatec is a global medical products and technologies company with a 10,000 strong workforce – providing products and services in nearly 100 countries across advanced wound care, ostomy care, continence care and infusion care.
Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. In 2022, we sold more than 850 million products generating revenues of over $2 billion.
In April 2023, Convatec acquired a highly innovative antimicrobial technology platform from 30 Technology, the world leader in clinical nitric oxide generation technology. Convatec is well placed to commercialise this technology and will explore its application across business categories. The acquisition included its Milton Park lab and personnel.